Recent News
Eric Vengroff, Cannabis Daily TORONTO, ON (October 17, 2018) – Just in time for Cannabis Day One, a new platform connecting job seekers with employment opportunities in the Canadian cannabis industry launches in Canada today. Careers Cannabis is an online job search engine, making it faster for employers and job […]
JACQUIE MILLER, Postmedia Network, Inc. Cannabis companies are intensifying efforts to get attention for their brands even as Health Canada launches another crackdown on the promotion of pot. Oct 11, 2018 -There appears to be a game of regulatory chicken emerging. Some companies are seemingly testing the boundaries with billboards, […]
Opinion Editorial – by Eric Vengroff, Financial Analyst, Cannabis Daily “Everything that follows, is a result of what you see here…” Dr. Alfred Lanning’s hologram from the movie I, Robot, 2004 As Canada collectively gets ready for recreational adult-use cannabis next week, the Globe and Mail reported last week that Canada’s […]
Following headlines from Constellation Brands and Coca-Cola, BDS Analytics looks at how branded beverage product market share may change. Eric Sandy, Cannabis Business Times Two of the biggest cannabis industry headlines to close out an already very busy summer involved Constellation Brands’ $4-billion investment in Canopy Growth Corp. and Coca-Cola’s […]
By Max A. Cherney, Tech reporter, MarketWatch Canada-based Canopy Growth Corp. has withdrawn a trademark it filed in August for the phrase “Chronic By Dre,” according to a company spokesman. “Chronic By Dre” refers to the 1992 album by rapper and music mogul Andre Young, also known as Dr. Dre. It […]
Eric Sandy, Cannabis Business Times Distribution Grower/Agriculture Infused Products Medical News Politics September 28, 2018 – This week, the Drug Enforcement Administration placed Epidiolex, a drug that includes cannabis-derived compounds—specifically, cannabidiol (CBD)—in Schedule V, a far less restrictive oversight category than CBD’s Schedule I classification. Following the drug’s recent approval from the Food and Drug […]
Opinion editorial By Eric Vengroff, Financial Analyst, Cannabis Daily As reported by the Globe and Mail this morning, the Ontario government is putting in place a set of regulations that will have widespread implications for both business owners and consumers. These moves will also be major steps in normalizing and […]
Tilray (NASDAQ: TLRY), the stock that investors and speculators can’t seem to get enough of right now, was reported as being worth more on paper than some of Canada’s leading established retail conglomerates such as Canadian Tire and Loblaw Companies Ltd. To put this in perspective, a company that sold […]
By Ciara Linnane, Corporate News Editor, MarketWatch Cannabis stocks were higher across the board on Tuesday, led by Tilray Inc., which rallied sharply on news that the U.S. Drug Enforcement Administration has approved its plan to import a marijuana product and test its efficacy in treating a neurological disorder that […]
By Eric Vengroff, Financial Analyst, Cannabis Daily Multiple news sources have reported that Tilray (NASDAQ:TLRY) has terminated its contract with Namaste, roughly 10 days after the announcement of the deal. Brandon A. Dorfman of Potnetwork reported that the self-described “Amazon of Weed”, Namaste Technologies (OTCMKTS:NXTTF) held a stockholder pledge party and according […]
